Position
Citadel in Sutro Biopharma, Inc.
Back to the book · All holders of STRO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $845.3K$24.91 → $33.20
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 32.1K | $371.2K | — | — | — | 0.0% |
| Q1 2026 | 117.5K | $2.93M | $24.91 | $428K | $2.13M | 0.0% |
| Q2 2026 | 102K | $3.39M | $33.20 | $845.3K | −$387.9K | 0.0% |